-
1
-
-
84858175257
-
Genital human papillomavirus infections: Current and prospective therapies
-
Stanley, M.A. Genital human papillomavirus infections: current and prospective therapies. J. Gen. Virol 2012, 93, 681-691.
-
(2012)
J. Gen. Virol
, vol.93
, pp. 681-691
-
-
Stanley, M.A.1
-
2
-
-
63249083596
-
Case 10-2009. A 23-year-old woman with an abnormal Papanicolaou smear
-
Case records of the Massachusetts General Hospital
-
Goldstein, M.A.; Goodman, A.; del Carmen, M.G.; Wilbur, D.C. Case records of the Massachusetts General Hospital. Case 10-2009. A 23-year-old woman with an abnormal Papanicolaou smear. N. Engl. J. Med. 2009, 360, 1337-1344.
-
(2009)
N. Engl. J. Med.
, vol.360
, pp. 1337-1344
-
-
Goldstein, M.A.1
Goodman, A.2
del Carmen, M.G.3
Wilbur, D.C.4
-
3
-
-
52649132384
-
The interaction between human papillomavirus type 16 and FADD is mediated by a novel E6 binding domain
-
Tungteakkhun, S.S.; Filippova, M.; Neidigh, J.W.; Fodor, N.; Duerksen-Hughes, P.J. The interaction between human papillomavirus type 16 and FADD is mediated by a novel E6 binding domain. J. Virol. 2008, 82, 9600-9614.
-
(2008)
J. Virol.
, vol.82
, pp. 9600-9614
-
-
Tungteakkhun, S.S.1
Filippova, M.2
Neidigh, J.W.3
Fodor, N.4
Duerksen-Hughes, P.J.5
-
4
-
-
77954955259
-
Human papillomavirus oncoproteins: Pathways to transformation
-
Moody, C.A.; Laimins, L.A. Human papillomavirus oncoproteins: Pathways to transformation. Nat. Rev. Cancer 2010, 10, 550-560.
-
(2010)
Nat. Rev. Cancer
, vol.10
, pp. 550-560
-
-
Moody, C.A.1
Laimins, L.A.2
-
5
-
-
23444447828
-
Crosstalk between the human papillomavirus E2 transcriptional activator and the E6 oncoprotein
-
Grm, H.S.; Massimi, P.; Gammoh, N.; Banks, L. Crosstalk between the human papillomavirus E2 transcriptional activator and the E6 oncoprotein. Oncogene 2005, 24, 5149-5164.
-
(2005)
Oncogene
, vol.24
, pp. 5149-5164
-
-
Grm, H.S.1
Massimi, P.2
Gammoh, N.3
Banks, L.4
-
6
-
-
0031046848
-
Apoptosis and disease: Regulation and clinical relevance of programmed cell death
-
Rudin, C.M.; Thompson, C.B. Apoptosis and disease: regulation and clinical relevance of programmed cell death. Annu. Rev. Med. 1997, 48, 267-281.
-
(1997)
Annu. Rev. Med.
, vol.48
, pp. 267-281
-
-
Rudin, C.M.1
Thompson, C.B.2
-
7
-
-
0037268529
-
Involvement of TRAIL and its receptors in viral hepatitis
-
Mundt, B.; Kuhnel, F.; Zender, L.; Paul, Y.; Tillmann, H.; Trautwein, C.; Manns, M.P.; Kubicka, S. Involvement of TRAIL and its receptors in viral hepatitis. Faseb. J. 2003, 17, 94-96.
-
(2003)
Faseb. J.
, vol.17
, pp. 94-96
-
-
Mundt, B.1
Kuhnel, F.2
Zender, L.3
Paul, Y.4
Tillmann, H.5
Trautwein, C.6
Manns, M.P.7
Kubicka, S.8
-
8
-
-
0042329608
-
Apoptosis in systemic lupus erythematosus
-
White, S.; Rosen, A. Apoptosis in systemic lupus erythematosus. Curr Opin Rheumatol 2003, 15, 557-562.
-
(2003)
Curr Opin Rheumatol
, vol.15
, pp. 557-562
-
-
White, S.1
Rosen, A.2
-
9
-
-
0036720435
-
Development of a human neuronal cell model for human immunodeficiency virus (HIV)-infected macrophage-induced neurotoxicity: Apoptosis induced by HIV type 1 primary isolates and evidence for involvement of the Bcl-2/Bcl-xL-sensitive intrinsic apoptosis pathway
-
Chen, W.; Sulcove, J.; Frank, I.; Jaffer, S.; Ozdener, H.; Kolson, D.L. Development of a human neuronal cell model for human immunodeficiency virus (HIV)-infected macrophage-induced neurotoxicity: apoptosis induced by HIV type 1 primary isolates and evidence for involvement of the Bcl-2/Bcl-xL-sensitive intrinsic apoptosis pathway. J. Virol. 2002, 76, 9407-9419.
-
(2002)
J. Virol.
, vol.76
, pp. 9407-9419
-
-
Chen, W.1
Sulcove, J.2
Frank, I.3
Jaffer, S.4
Ozdener, H.5
Kolson, D.L.6
-
10
-
-
33746886979
-
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
-
Fulda, S.; Debatin, K.M. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 2006, 25, 4798-4811.
-
(2006)
Oncogene
, vol.25
, pp. 4798-4811
-
-
Fulda, S.1
Debatin, K.M.2
-
11
-
-
29144495592
-
Near death experiences: Poxvirus regulation of apoptotic death
-
Taylor, J.M.; Barry, M. Near death experiences: poxvirus regulation of apoptotic death. Virology 2006, 344, 139-150.
-
(2006)
Virology
, vol.344
, pp. 139-150
-
-
Taylor, J.M.1
Barry, M.2
-
12
-
-
0642283970
-
Regulation of proliferation, survival and apoptosis by members of the TNF superfamily
-
Gaur, U.; Aggarwal, B.B. Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem. Pharmacol.2003, 66, 1403-1408.
-
(2003)
Biochem. Pharmacol.
, vol.66
, pp. 1403-1408
-
-
Gaur, U.1
Aggarwal, B.B.2
-
13
-
-
49049086338
-
Ligand-based targeting of apoptosis in cancer: The potential of recombinant human apoptosis ligand 2/Tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL)
-
Ashkenazi, A.; Holland, P.; Eckhardt, S.G. Ligand-based targeting of apoptosis in cancer: The potential of recombinant human apoptosis ligand 2/Tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL). J. Clin. Oncol. 2008, 26, 3621-3630.
-
(2008)
J. Clin. Oncol.
, vol.26
, pp. 3621-3630
-
-
Ashkenazi, A.1
Holland, P.2
Eckhardt, S.G.3
-
14
-
-
0032536771
-
Two CD95 (APO-1/Fas) signaling pathways
-
Scaffidi, C.; Fulda, S.; Srinivasan, A.; Friesen, C.; Li, F.; Tomaselli, K.J.; Debatin, K.M.; Krammer, P.H.; Peter, M.E. Two CD95 (APO-1/Fas) signaling pathways. Embo J. 1998, 17, 1675-1687.
-
(1998)
Embo J.
, vol.17
, pp. 1675-1687
-
-
Scaffidi, C.1
Fulda, S.2
Srinivasan, A.3
Friesen, C.4
Li, F.5
Tomaselli, K.J.6
Debatin, K.M.7
Krammer, P.H.8
Peter, M.E.9
-
15
-
-
0032832881
-
Differences between CD95 type I and II cells detected with the CD95 ligand
-
Schmitz, I.; Walczak, H.; Krammer, P.H.; Peter, M.E. Differences between CD95 type I and II cells detected with the CD95 ligand. Cell. Death Differ. 1999, 6, 821-822.
-
(1999)
Cell. Death Differ.
, vol.6
, pp. 821-822
-
-
Schmitz, I.1
Walczak, H.2
Krammer, P.H.3
Peter, M.E.4
-
16
-
-
0035923653
-
Caspase-10 is an initiator caspase in death receptor signaling
-
Wang, J.; Chun, H.J.; Wong, W.; Spencer, D.M.; Lenardo, M.J. Caspase-10 is an initiator caspase in death receptor signaling. Proc. Natl. Acad. Sci. USA 2001, 98, 13884-13888.
-
(2001)
Proc. Natl. Acad. Sci. USA
, vol.98
, pp. 13884-13888
-
-
Wang, J.1
Chun, H.J.2
Wong, W.3
Spencer, D.M.4
Lenardo, M.J.5
-
17
-
-
2442453730
-
The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress
-
Tinel, A.; Tschopp, J. The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 2004, 304, 843-846.
-
(2004)
Science
, vol.304
, pp. 843-846
-
-
Tinel, A.1
Tschopp, J.2
-
18
-
-
0035019143
-
Caspase-2 activation is redundant during seizure-induced neuronal death
-
Henshall, D.C.; Skradski, S.L.; Bonislawski, D.P.; Lan, J.Q.; Simon, R.P. Caspase-2 activation is redundant during seizure-induced neuronal death. J. Neurochem. 2001, 77, 886-895.
-
(2001)
J. Neurochem.
, vol.77
, pp. 886-895
-
-
Henshall, D.C.1
Skradski, S.L.2
Bonislawski, D.P.3
Lan, J.Q.4
Simon, R.P.5
-
19
-
-
80052746929
-
Caspase-2 is required for DNA damage-induced expression of the CDK inhibitor p21(WAF1/CIP1)
-
Sohn, D.; Budach, W.; Janicke, R.U. Caspase-2 is required for DNA damage-induced expression of the CDK inhibitor p21(WAF1/CIP1). Cell. Death Differ. 2011, 18, 1664-1674.
-
(2011)
Cell. Death Differ.
, vol.18
, pp. 1664-1674
-
-
Sohn, D.1
Budach, W.2
Janicke, R.U.3
-
20
-
-
0034641963
-
Defying death after DNA damage
-
Rich, T.; Allen, R.L.; Wyllie, A.H. Defying death after DNA damage. Nature 2000, 407, 777-783.
-
(2000)
Nature
, vol.407
, pp. 777-783
-
-
Rich, T.1
Allen, R.L.2
Wyllie, A.H.3
-
21
-
-
27644542306
-
Apoptosis: Mechanisms and relevance in cancer
-
Vermeulen, K.; Van Bockstaele, D.R.; Berneman, Z.N. Apoptosis: Mechanisms and relevance in cancer. Ann. Hematol. 2005, 84, 627-639.
-
(2005)
Ann. Hematol.
, vol.84
, pp. 627-639
-
-
Vermeulen, K.1
van Bockstaele, D.R.2
Berneman, Z.N.3
-
22
-
-
0030715323
-
Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
-
Li, P.; Nijhawan, D.; Budihardjo, I.; Srinivasula, S.M.; Ahmad, M.; Alnemri, E.S.; Wang, X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 1997, 91, 479-489.
-
(1997)
Cell.
, vol.91
, pp. 479-489
-
-
Li, P.1
Nijhawan, D.2
Budihardjo, I.3
Srinivasula, S.M.4
Ahmad, M.5
Alnemri, E.S.6
Wang, X.7
-
23
-
-
0033596980
-
An APAF-1. cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9
-
Zou, H.; Li, Y.; Liu, X.; Wang, X. An APAF-1. cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol Chem 1999, 274, 11549-11556.
-
(1999)
J. Biol Chem
, vol.274
, pp. 11549-11556
-
-
Zou, H.1
Li, Y.2
Liu, X.3
Wang, X.4
-
24
-
-
2942532135
-
Analysis of the composition, assembly kinetics and activity of native Apaf-1 apoptosomes
-
Hill, M.M.; Adrain, C.; Duriez, P.J.; Creagh, E.M.; Martin, S.J. Analysis of the composition, assembly kinetics and activity of native Apaf-1 apoptosomes. Embo J. 2004, 23, 2134-2145.
-
(2004)
Embo J.
, vol.23
, pp. 2134-2145
-
-
Hill, M.M.1
Adrain, C.2
Duriez, P.J.3
Creagh, E.M.4
Martin, S.J.5
-
25
-
-
0030820875
-
Caspase-3-generated fragment of gelsolin: Effector of morphological change in apoptosis
-
Kothakota, S.; Azuma, T.; Reinhard, C.; Klippel, A.; Tang, J.; Chu, K.; McGarry, T.J.; Kirschner, M.W.; Koths, K.; Kwiatkowski, D.J.; et al. Caspase-3-generated fragment of gelsolin: Effector of morphological change in apoptosis. Science 1997, 278, 294-298.
-
(1997)
Science
, vol.278
, pp. 294-298
-
-
Kothakota, S.1
Azuma, T.2
Reinhard, C.3
Klippel, A.4
Tang, J.5
Chu, K.6
McGarry, T.J.7
Kirschner, M.W.8
Koths, K.9
Kwiatkowski, D.J.10
-
26
-
-
72249120375
-
Caspase-mediated protein kinase C-delta cleavage is necessary for apoptosis of vascular smooth muscle cells
-
Kato, K.; Yamanouchi, D.; Esbona, K.; Kamiya, K.; Zhang, F.; Kent, K.C.; Liu, B. Caspase-mediated protein kinase C-delta cleavage is necessary for apoptosis of vascular smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 2009, 297, H2253-2261.
-
(2009)
Am. J. Physiol. Heart Circ. Physiol.
, vol.297
-
-
Kato, K.1
Yamanouchi, D.2
Esbona, K.3
Kamiya, K.4
Zhang, F.5
Kent, K.C.6
Liu, B.7
-
27
-
-
0026474669
-
The adenovirus E3 region 14.7 kDa protein, heat and sodium arsenite inhibit the TNF-induced release of arachidonic acid
-
Zilli, D.; Voelkel-Johnson, C.; Skinner, T.; Laster, S.M. The adenovirus E3 region 14.7 kDa protein, heat and sodium arsenite inhibit the TNF-induced release of arachidonic acid. Biochem. Biophys. Res. Commun. 1992, 188, 177-183.
-
(1992)
Biochem. Biophys. Res. Commun.
, vol.188
, pp. 177-183
-
-
Zilli, D.1
Voelkel-Johnson, C.2
Skinner, T.3
Laster, S.M.4
-
28
-
-
75649111205
-
Viral TNF inhibitors as potential therapeutics
-
Rahman, M.M.; Lucas, A.R.; McFadden, G. Viral TNF inhibitors as potential therapeutics. Adv. Exp. Med. Biol. 2009, 666, 64-77.
-
(2009)
Adv. Exp. Med. Biol.
, vol.666
, pp. 64-77
-
-
Rahman, M.M.1
Lucas, A.R.2
McFadden, G.3
-
29
-
-
12644286556
-
Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas-and TNFR1-induced apoptosis
-
Bertin, J.; Armstrong, R.C.; Ottilie, S.; Martin, D.A.; Wang, Y.; Banks, S.; Wang, G.H.; Senkevich, T.G.; Alnemri, E.S.; Moss, B.; Lenardo, J. et al. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas-and TNFR1-induced apoptosis. Proc. Natl. Acad. Sci. USA 1997, 94, 1172-1176.
-
(1997)
Proc. Natl. Acad. Sci. USA
, vol.94
, pp. 1172-1176
-
-
Bertin, J.1
Armstrong, R.C.2
Ottilie, S.3
Martin, D.A.4
Wang, Y.5
Banks, S.6
Wang, G.H.7
Senkevich, T.G.8
Alnemri, E.S.9
Moss, B.10
Lenardo, J.11
-
30
-
-
84865821950
-
Effects of Epstein-Barr virus infection on the development of multiple myeloma after liver transplantation
-
Zhang, Y.; Zhao, H.; He, X.; Zheng, S.; Wang, T.; Yan, D.; Sun, J.; Lu, X.; Wen, J.; Lau, W.Y. Effects of Epstein-Barr virus infection on the development of multiple myeloma after liver transplantation. Sci. China Life Sci. 2012, 55, 735-743.
-
(2012)
Sci. China Life Sci.
, vol.55
, pp. 735-743
-
-
Zhang, Y.1
Zhao, H.2
He, X.3
Zheng, S.4
Wang, T.5
Yan, D.6
Sun, J.7
Lu, X.8
Wen, J.9
Lau, W.Y.10
-
31
-
-
84855265398
-
Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis
-
Cai, Q.; Guo, Y.; Xiao, B.; Banerjee, S.; Saha, A.; Lu, J.; Glisovic, T.; Robertson, E.S. Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis. PLoS Pathog. 2011, 7, e1002418.
-
(2011)
PLoS Pathog.
, vol.7
-
-
Cai, Q.1
Guo, Y.2
Xiao, B.3
Banerjee, S.4
Saha, A.5
Lu, J.6
Glisovic, T.7
Robertson, E.S.8
-
32
-
-
0031931726
-
Differential requirements for conserved E2 binding sites in the life cycle of oncogenic human papillomavirus type 31
-
Stubenrauch, F.; Lim, H.B.; Laimins, L.A. Differential requirements for conserved E2 binding sites in the life cycle of oncogenic human papillomavirus type 31. J. Virol 1998, 72, 1071-1077.
-
(1998)
J. Virol
, vol.72
, pp. 1071-1077
-
-
Stubenrauch, F.1
Lim, H.B.2
Laimins, L.A.3
-
33
-
-
0033587681
-
Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes
-
Thomas, J.T.; Hubert, W.G.; Ruesch, M.N.; Laimins, L.A. Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes. Proc. Natl. Acad. Sci. USA 1999, 96, 8449-8454.
-
(1999)
Proc. Natl. Acad. Sci. USA
, vol.96
, pp. 8449-8454
-
-
Thomas, J.T.1
Hubert, W.G.2
Ruesch, M.N.3
Laimins, L.A.4
-
34
-
-
0036827961
-
Genetic analysis of high-risk e6 in episomal maintenance of human papillomavirus genomes in primary human keratinocytes
-
Park, R.B.; Androphy, E.J. Genetic analysis of high-risk e6 in episomal maintenance of human papillomavirus genomes in primary human keratinocytes. J. Virol. 2002, 76, 11359-11364.
-
(2002)
J. Virol.
, vol.76
, pp. 11359-11364
-
-
Park, R.B.1
Androphy, E.J.2
-
35
-
-
0027289398
-
Growth and differentiation of human papillomavirus type 31b positive human cervical cell lines
-
De Geest, K.; Turyk, M.E.; Hosken, M.I.; Hudson, J.B.; Laimins, L.A.; Wilbanks, G.D. Growth and differentiation of human papillomavirus type 31b positive human cervical cell lines. Gynecol Oncol 1993, 49, 303-310.
-
(1993)
Gynecol Oncol
, vol.49
, pp. 303-310
-
-
de Geest, K.1
Turyk, M.E.2
Hosken, M.I.3
Hudson, J.B.4
Laimins, L.A.5
Wilbanks, G.D.6
-
36
-
-
0031725627
-
The immunology of genital human papilloma virus infection
-
discussion 20-12
-
Stanley, M. The immunology of genital human papilloma virus infection. Eur. J. Dermatol. 1998, 8, 8-12; discussion 20-12.
-
(1998)
Eur. J. Dermatol.
, vol.8
, pp. 8-12
-
-
Stanley, M.1
-
37
-
-
14744285753
-
The papillomavirus life cycle
-
Doorbar, J. The papillomavirus life cycle. J. Clin. Virol. 2005, 32, S7-S15.
-
(2005)
J. Clin. Virol.
, vol.32
-
-
Doorbar, J.1
-
38
-
-
0035956258
-
Biological activities and molecular targets of the human papillomavirus E7 oncoprotein
-
Munger, K.; Basile, J.R.; Duensing, S.; Eichten, A.; Gonzalez, S.L.; Grace, M.; Zacny, V.L. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 2001, 20, 7888-7898.
-
(2001)
Oncogene
, vol.20
, pp. 7888-7898
-
-
Munger, K.1
Basile, J.R.2
Duensing, S.3
Eichten, A.4
Gonzalez, S.L.5
Grace, M.6
Zacny, V.L.7
-
39
-
-
33746268107
-
Partitioning viral genomes in mitosis: Same idea, different targets
-
McBride, A.A.; Oliveira, J.G.; McPhillips, M.G. Partitioning viral genomes in mitosis: Same idea, different targets. Cell. Cycle 2006, 5, 1499-1502.
-
(2006)
Cell. Cycle
, vol.5
, pp. 1499-1502
-
-
McBride, A.A.1
Oliveira, J.G.2
McPhillips, M.G.3
-
40
-
-
0842325980
-
The viral E4 protein is required for the completion of the cottontail rabbit papillomavirus productive cycle in vivo
-
Peh, W.L.; Brandsma, J.L.; Christensen, N.D.; Cladel, N.M.; Wu, X.; Doorbar, J. The viral E4 protein is required for the completion of the cottontail rabbit papillomavirus productive cycle in vivo. J. Virol. 2004, 78, 2142-2151.
-
(2004)
J. Virol.
, vol.78
, pp. 2142-2151
-
-
Peh, W.L.1
Brandsma, J.L.2
Christensen, N.D.3
Cladel, N.M.4
Wu, X.5
Doorbar, J.6
-
41
-
-
0037369075
-
Quantitative role of the human papillomavirus type 16 E5 gene during the productive stage of the viral life cycle
-
Genther, S.M.; Sterling, S.; Duensing, S.; Munger, K.; Sattler, C.; Lambert, P.F. Quantitative role of the human papillomavirus type 16 E5 gene during the productive stage of the viral life cycle. J. Virol 2003, 77, 2832-2842.
-
(2003)
J. Virol
, vol.77
, pp. 2832-2842
-
-
Genther, S.M.1
Sterling, S.2
Duensing, S.3
Munger, K.4
Sattler, C.5
Lambert, P.F.6
-
42
-
-
0041967157
-
Human papillomaviruses: Targeting differentiating epithelial cells for malignant transformation
-
Fehrmann, F.; Laimins, L.A. Human papillomaviruses: Targeting differentiating epithelial cells for malignant transformation. Oncogene 2003, 22, 5201-5207.
-
(2003)
Oncogene
, vol.22
, pp. 5201-5207
-
-
Fehrmann, F.1
Laimins, L.A.2
-
43
-
-
0026671624
-
Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes
-
Hummel, M.; Hudson, J.B.; Laimins, L.A. Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes. J. Virol 1992, 66, 6070-6080.
-
(1992)
J. Virol
, vol.66
, pp. 6070-6080
-
-
Hummel, M.1
Hudson, J.B.2
Laimins, L.A.3
-
44
-
-
0030959260
-
Characterization of late gene transcripts expressed during vegetative replication of human papillomavirus type 31b
-
Ozbun, M.A.; Meyers, C. Characterization of late gene transcripts expressed during vegetative replication of human papillomavirus type 31b. J. Virol. 1997, 71, 5161-5172.
-
(1997)
J. Virol.
, vol.71
, pp. 5161-5172
-
-
Ozbun, M.A.1
Meyers, C.2
-
45
-
-
70449095899
-
A novel interaction between the human papillomavirus type 16 E2 and E1--E4 proteins leads to stabilization of E2
-
Davy, C.; McIntosh, P.; Jackson, D.J.; Sorathia, R.; Miell, M.; Wang, Q.; Khan, J.; Soneji, Y.; Doorbar, J. A novel interaction between the human papillomavirus type 16 E2 and E1--E4 proteins leads to stabilization of E2. Virology 2009, 394, 266-275.
-
(2009)
Virology
, vol.394
, pp. 266-275
-
-
Davy, C.1
McIntosh, P.2
Jackson, D.J.3
Sorathia, R.4
Miell, M.5
Wang, Q.6
Khan, J.7
Soneji, Y.8
Doorbar, J.9
-
46
-
-
77956004466
-
E1--E4-mediated keratin phosphorylation and ubiquitylation: A mechanism for keratin depletion in HPV16-infected epithelium
-
McIntosh, P.B.; Laskey, P.; Sullivan, K.; Davy, C.; Wang, Q.; Jackson, D.J.; Griffin, H.M.; Doorbar, J. E1--E4-mediated keratin phosphorylation and ubiquitylation: A mechanism for keratin depletion in HPV16-infected epithelium. J. Cell Sci. 2010, 123, 2810-2822.
-
(2010)
J. Cell Sci
, vol.123
, pp. 2810-2822
-
-
McIntosh, P.B.1
Laskey, P.2
Sullivan, K.3
Davy, C.4
Wang, Q.5
Jackson, D.J.6
Griffin, H.M.7
Doorbar, J.8
-
47
-
-
81055131727
-
Papillomavirus E5: The smallest oncoprotein with many functions
-
Venuti, A.; Paolini, F.; Nasir, L.; Corteggio, A.; Roperto, S.; Campo, M.S.; Borzacchiello, G. Papillomavirus E5: The smallest oncoprotein with many functions. Mol. Cancer 2011, 10, 140.
-
(2011)
Mol. Cancer
, vol.10
, pp. 140
-
-
Venuti, A.1
Paolini, F.2
Nasir, L.3
Corteggio, A.4
Roperto, S.5
Campo, M.S.6
Borzacchiello, G.7
-
48
-
-
0032929698
-
Evidence that apoptosis and terminal differentiation of epidermal keratinocytes are distinct processes
-
Gandarillas, A.; Goldsmith, L.A.; Gschmeissner, S.; Leigh, I.M.; Watt, F.M. Evidence that apoptosis and terminal differentiation of epidermal keratinocytes are distinct processes. Exp. Dermatol. 1999, 8, 71-79.
-
(1999)
Exp. Dermatol.
, vol.8
, pp. 71-79
-
-
Gandarillas, A.1
Goldsmith, L.A.2
Gschmeissner, S.3
Leigh, I.M.4
Watt, F.M.5
-
49
-
-
0034614637
-
The hallmarks of cancer
-
Hanahan, D.; Weinberg, R.A. The hallmarks of cancer. Cell 2000, 100, 57-70.
-
(2000)
Cell
, vol.100
, pp. 57-70
-
-
Hanahan, D.1
Weinberg, R.A.2
-
50
-
-
0024076907
-
Structural and mutational analysis of E2 trans-activating proteins of papillomaviruses reveals three distinct functional domains
-
Giri, I.; Yaniv, M. Structural and mutational analysis of E2 trans-activating proteins of papillomaviruses reveals three distinct functional domains. Embo. J. 1988, 7, 2823-2829.
-
(1988)
Embo. J.
, vol.7
, pp. 2823-2829
-
-
Giri, I.1
Yaniv, M.2
-
51
-
-
0031025688
-
Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis
-
Desaintes, C.; Demeret, C.; Goyat, S.; Yaniv, M.; Thierry, F. Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis. Embo. J. 1997, 16, 504-514.
-
(1997)
Embo. J.
, vol.16
, pp. 504-514
-
-
Desaintes, C.1
Demeret, C.2
Goyat, S.3
Yaniv, M.4
Thierry, F.5
-
52
-
-
0037448656
-
Transcription-independent triggering of the extrinsic pathway of apoptosis by human papillomavirus 18 E2 protein
-
Demeret, C.; Garcia-Carranca, A.; Thierry, F. Transcription-independent triggering of the extrinsic pathway of apoptosis by human papillomavirus 18 E2 protein. Oncogene 2003, 22, 168-175.
-
(2003)
Oncogene
, vol.22
, pp. 168-175
-
-
Demeret, C.1
Garcia-Carranca, A.2
Thierry, F.3
-
53
-
-
49949089516
-
Direct activation of caspase 8 by the proapoptotic E2 protein of HPV18 independent of adaptor proteins
-
Thierry, F.; Demeret, C. Direct activation of caspase 8 by the proapoptotic E2 protein of HPV18 independent of adaptor proteins. Cell Death Differ. 2008, 15, 1356-1363.
-
(2008)
Cell Death Differ.
, vol.15
, pp. 1356-1363
-
-
Thierry, F.1
Demeret, C.2
-
54
-
-
0033576648
-
Interaction between the HPV-16 E2 transcriptional activator and p53
-
Massimi, P.; Pim, D.; Bertoli, C.; Bouvard, V.; Banks, L. Interaction between the HPV-16 E2 transcriptional activator and p53. Oncogene 1999, 18, 7748-7754.
-
(1999)
Oncogene
, vol.18
, pp. 7748-7754
-
-
Massimi, P.1
Pim, D.2
Bertoli, C.3
Bouvard, V.4
Banks, L.5
-
55
-
-
0034614650
-
The human papillomavirus (HPV) 16 E2 protein induces apoptosis in the absence of other HPV proteins and via a p53-dependent pathway
-
Webster, K.; Parish, J.; Pandya, M.; Stern, P.L.; Clarke, A.R.; Gaston, K. The human papillomavirus (HPV) 16 E2 protein induces apoptosis in the absence of other HPV proteins and via a p53-dependent pathway. J. Biol. Chem. 2000, 275, 87-94.
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 87-94
-
-
Webster, K.1
Parish, J.2
Pandya, M.3
Stern, P.L.4
Clarke, A.R.5
Gaston, K.6
-
56
-
-
34447117524
-
A cancer cell-specific inducer of apoptosis
-
Green, K.L.; Brown, C.; Roeder, G.E.; Southgate, T.D.; Gaston, K. A cancer cell-specific inducer of apoptosis. Hum. Gene Ther. 2007, 18, 547-561.
-
(2007)
Hum. Gene Ther.
, vol.18
, pp. 547-561
-
-
Green, K.L.1
Brown, C.2
Roeder, G.E.3
Southgate, T.D.4
Gaston, K.5
-
57
-
-
0027216860
-
The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes
-
Straight, S.W.; Hinkle, P.M.; Jewers, R.J.; McCance, D.J. The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes. J. Virol. 1993, 67, 4521-4532.
-
(1993)
J. Virol.
, vol.67
, pp. 4521-4532
-
-
Straight, S.W.1
Hinkle, P.M.2
Jewers, R.J.3
McCance, D.J.4
-
58
-
-
23044448002
-
Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene
-
Genther Williams, S.M.; Disbrow, G.L.; Schlegel, R.; Lee, D.; Threadgill, D.W.; Lambert, P.F. Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene. Cancer Res. 2005, 65, 6534-6542.
-
(2005)
Cancer Res.
, vol.65
, pp. 6534-6542
-
-
Genther Williams, S.M.1
Disbrow, G.L.2
Schlegel, R.3
Lee, D.4
Threadgill, D.W.5
Lambert, P.F.6
-
59
-
-
17844396023
-
HPV16 E5 protein disrupts the c-Cbl-EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes
-
Zhang, B.; Srirangam, A.; Potter, D.A.; Roman, A. HPV16 E5 protein disrupts the c-Cbl-EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes. Oncogene 2005, 24, 2585-2588.
-
(2005)
Oncogene
, vol.24
, pp. 2585-2588
-
-
Zhang, B.1
Srirangam, A.2
Potter, D.A.3
Roman, A.4
-
60
-
-
77957201861
-
The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification
-
Suprynowicz, F.A.; Krawczyk, E.; Hebert, J.D.; Sudarshan, S.R.; Simic, V.; Kamonjoh, C.M.; Schlegel, R. The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification. J. Virol. 2010, 84, 10619-10629.
-
(2010)
J. Virol.
, vol.84
, pp. 10619-10629
-
-
Suprynowicz, F.A.1
Krawczyk, E.2
Hebert, J.D.3
Sudarshan, S.R.4
Simic, V.5
Kamonjoh, C.M.6
Schlegel, R.7
-
61
-
-
13744254574
-
Cyclooxygenase-2 and epidermal growth factor receptor: Pharmacologic targets for chemoprevention
-
Dannenberg, A.J.; Lippman, S.M.; Mann, J.R.; Subbaramaiah, K.; DuBois, R.N. Cyclooxygenase-2 and epidermal growth factor receptor: Pharmacologic targets for chemoprevention. J. Clin Oncol 2005, 23, 254-266.
-
(2005)
J. Clin Oncol
, vol.23
, pp. 254-266
-
-
Dannenberg, A.J.1
Lippman, S.M.2
Mann, J.R.3
Subbaramaiah, K.4
DuBois, R.N.5
-
62
-
-
0036888941
-
The human papillomavirus type 16 E5 protein impairs TRAIL-and FasL-mediated apoptosis in HaCaT cells by different mechanisms
-
Kabsch, K.; Alonso, A. The human papillomavirus type 16 E5 protein impairs TRAIL-and FasL-mediated apoptosis in HaCaT cells by different mechanisms. J. Virol 2002, 76, 12162-12172.
-
(2002)
J. Virol
, vol.76
, pp. 12162-12172
-
-
Kabsch, K.1
Alonso, A.2
-
63
-
-
0036132827
-
E5 protein of human papillomavirus type 16 protects human foreskin keratinocytes from UV B-irradiation-induced apoptosis
-
Zhang, B.; Spandau, D.F.; Roman, A. E5 protein of human papillomavirus type 16 protects human foreskin keratinocytes from UV B-irradiation-induced apoptosis. J. Virol 2002, 76, 220-231.
-
(2002)
J. Virol
, vol.76
, pp. 220-231
-
-
Zhang, B.1
Spandau, D.F.2
Roman, A.3
-
64
-
-
77950905948
-
Human papillomavirus type 16 E5 protein inhibits hydrogen-peroxide-induced apoptosis by stimulating ubiquitin-proteasome-mediated degradation of Bax in human cervical cancer cells
-
Oh, J.M.; Kim, S.H.; Cho, E.A.; Song, Y.S.; Kim, W.H.; Juhnn, Y.S. Human papillomavirus type 16 E5 protein inhibits hydrogen-peroxide-induced apoptosis by stimulating ubiquitin-proteasome-mediated degradation of Bax in human cervical cancer cells. Carcinogenesis 2010, 31, 402-410.
-
(2010)
Carcinogenesis
, vol.31
, pp. 402-410
-
-
Oh, J.M.1
Kim, S.H.2
Cho, E.A.3
Song, Y.S.4
Kim, W.H.5
Juhnn, Y.S.6
-
65
-
-
78049451565
-
Human papillomavirus type 16 E5 oncoprotein as a new target for cervical cancer treatment
-
Kim, M.K.; Kim, H.S.; Kim, S.H.; Oh, J.M.; Han, J.Y.; Lim, J.M.; Juhnn, Y.S.; Song, Y.S. Human papillomavirus type 16 E5 oncoprotein as a new target for cervical cancer treatment. Biochem. Pharmacol. 2010, 80, 1930-1935.
-
(2010)
Biochem. Pharmacol.
, vol.80
, pp. 1930-1935
-
-
Kim, M.K.1
Kim, H.S.2
Kim, S.H.3
Oh, J.M.4
Han, J.Y.5
Lim, J.M.6
Juhnn, Y.S.7
Song, Y.S.8
-
66
-
-
0025639158
-
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
-
Scheffner, M.; Werness, B.A.; Huibregtse, J.M.; Levine, A.J.; Howley, P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 1990, 63, 1129-1136.
-
(1990)
Cell.
, vol.63
, pp. 1129-1136
-
-
Scheffner, M.1
Werness, B.A.2
Huibregtse, J.M.3
Levine, A.J.4
Howley, P.M.5
-
67
-
-
0025932933
-
A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18
-
Huibregtse, J.M.; Scheffner, M.; Howley, P.M. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. Embo. J. 1991, 10, 4129-4135.
-
(1991)
Embo. J.
, vol.10
, pp. 4129-4135
-
-
Huibregtse, J.M.1
Scheffner, M.2
Howley, P.M.3
-
68
-
-
0025988293
-
Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation
-
Crook, T.; Tidy, J.A.; Vousden, K.H. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell. 1991, 67, 547-556.
-
(1991)
Cell.
, vol.67
, pp. 547-556
-
-
Crook, T.1
Tidy, J.A.2
Vousden, K.H.3
-
69
-
-
0028199891
-
Inhibition of p53 DNA binding by human papillomavirus E6 proteins
-
Lechner, M.S.; Laimins, L.A. Inhibition of p53 DNA binding by human papillomavirus E6 proteins. J. Virol. 1994, 68, 4262-4273.
-
(1994)
J. Virol.
, vol.68
, pp. 4262-4273
-
-
Lechner, M.S.1
Laimins, L.A.2
-
70
-
-
40749122639
-
HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background
-
Massimi, P.; Shai, A.; Lambert, P.; Banks, L. HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background. Oncogene 2008, 27, 1800-1804.
-
(2008)
Oncogene
, vol.27
, pp. 1800-1804
-
-
Massimi, P.1
Shai, A.2
Lambert, P.3
Banks, L.4
-
71
-
-
77953747537
-
E6-associated protein is required for human papillomavirus type 16 E6 to cause cervical cancer in mice
-
Shai, A.; Pitot, H.C.; Lambert, P.F. E6-associated protein is required for human papillomavirus type 16 E6 to cause cervical cancer in mice. Cancer Res. 2010, 70, 5064-5073.
-
(2010)
Cancer Res.
, vol.70
, pp. 5064-5073
-
-
Shai, A.1
Pitot, H.C.2
Lambert, P.F.3
-
72
-
-
0032506698
-
Inhibition of Bak-induced apoptosis by HPV-18 E6
-
Thomas, M.; Banks, L. Inhibition of Bak-induced apoptosis by HPV-18 E6. Oncogene 1998, 17, 2943-2954.
-
(1998)
Oncogene
, vol.17
, pp. 2943-2954
-
-
Thomas, M.1
Banks, L.2
-
73
-
-
0032493365
-
Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway
-
Gross-Mesilaty, S.; Reinstein, E.; Bercovich, B.; Tobias, K.E.; Schwartz, A.L.; Kahana, C.; Ciechanover, A. Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway. Proc. Natl. Acad. Sci. USA 1998, 95, 8058-8063.
-
(1998)
Proc. Natl. Acad. Sci. USA
, vol.95
, pp. 8058-8063
-
-
Gross-Mesilaty, S.1
Reinstein, E.2
Bercovich, B.3
Tobias, K.E.4
Schwartz, A.L.5
Kahana, C.6
Ciechanover, A.7
-
74
-
-
27944454386
-
The human papillomavirus 16 E6 protein can either protect or further sensitize cells to TNF: Effect of dose
-
Filippova, M.; Brown-Bryan, T.A.; Casiano, C.A.; Duerksen-Hughes, P.J. The human papillomavirus 16 E6 protein can either protect or further sensitize cells to TNF: Effect of dose. Cell. Death Differ. 2005, 12, 1622-1635.
-
(2005)
Cell. Death Differ.
, vol.12
, pp. 1622-1635
-
-
Filippova, M.1
Brown-Bryan, T.A.2
Casiano, C.A.3
Duerksen-Hughes, P.J.4
-
75
-
-
2942525121
-
The human papillomavirus 16 E6 protein binds to Fas-associated death domain and protects cells from Fas-triggered apoptosis
-
Filippova, M.; Parkhurst, L.; Duerksen-Hughes, P.J. The human papillomavirus 16 E6 protein binds to Fas-associated death domain and protects cells from Fas-triggered apoptosis. J. Biol. Chem. 2004, 279, 25729-25744.
-
(2004)
J. Biol. Chem.
, vol.279
, pp. 25729-25744
-
-
Filippova, M.1
Parkhurst, L.2
Duerksen-Hughes, P.J.3
-
76
-
-
58149374626
-
Complexes of human papillomavirus type 16 E6 proteins form pseudo-death-inducing signaling complex structures during tumor necrosis factor-mediated apoptosis
-
Filippova, M.; Filippov, V.A.; Kagoda, M.; Garnett, T.; Fodor, N.; Duerksen-Hughes, P.J. Complexes of human papillomavirus type 16 E6 proteins form pseudo-death-inducing signaling complex structures during tumor necrosis factor-mediated apoptosis. J. Virol 2009, 83, 210-227.
-
(2009)
J. Virol
, vol.83
, pp. 210-227
-
-
Filippova, M.1
Filippov, V.A.2
Kagoda, M.3
Garnett, T.4
Fodor, N.5
Duerksen-Hughes, P.J.6
-
77
-
-
33749617478
-
Accelerated degradation of FADD and procaspase 8 in cells expressing human papilloma virus 16 E6 impairs TRAIL-mediated apoptosis
-
Garnett, T.O.; Filippova, M.; Duerksen-Hughes, P.J. Accelerated degradation of FADD and procaspase 8 in cells expressing human papilloma virus 16 E6 impairs TRAIL-mediated apoptosis. Cell. Death Differ. 2006, 13, 1915-1926.
-
(2006)
Cell. Death Differ.
, vol.13
, pp. 1915-1926
-
-
Garnett, T.O.1
Filippova, M.2
Duerksen-Hughes, P.J.3
-
78
-
-
1242293656
-
Resistance to apoptosis of HPV 16-infected laryngeal cancer cells is associated with decreased Bak and increased Bcl-2 expression
-
Du, J.; Chen, G.G.; Vlantis, A.C.; Chan, P.K.; Tsang, R.K.; van Hasselt, C.A. Resistance to apoptosis of HPV 16-infected laryngeal cancer cells is associated with decreased Bak and increased Bcl-2 expression. Cancer Lett. 2004, 205, 81-88.
-
(2004)
Cancer Lett.
, vol.205
, pp. 81-88
-
-
Du, J.1
Chen, G.G.2
Vlantis, A.C.3
Chan, P.K.4
Tsang, R.K.5
van Hasselt, C.A.6
-
79
-
-
73949124438
-
The full-length isoform of human papillomavirus 16 E6 and its splice variant E6* bind to different sites on the procaspase 8 death effector domain
-
Tungteakkhun, S.S.; Filippova, M.; Fodor, N.; Duerksen-Hughes, P.J. The full-length isoform of human papillomavirus 16 E6 and its splice variant E6* bind to different sites on the procaspase 8 death effector domain. J. Virol. 2010, 84, 1453-1463.
-
(2010)
J. Virol.
, vol.84
, pp. 1453-1463
-
-
Tungteakkhun, S.S.1
Filippova, M.2
Fodor, N.3
Duerksen-Hughes, P.J.4
-
80
-
-
0037077205
-
The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis
-
Filippova, M.; Song, H.; Connolly, J.L.; Dermody, T.S.; Duerksen-Hughes, P.J. The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis. J. Biol. Chem. 2002, 277, 21730-21739.
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 21730-21739
-
-
Filippova, M.1
Song, H.2
Connolly, J.L.3
Dermody, T.S.4
Duerksen-Hughes, P.J.5
-
81
-
-
31644438582
-
Effects of human papillomavirus type 16 oncoproteins on survivin gene expression
-
Borbely, A.A.; Murvai, M.; Konya, J.; Beck, Z.; Gergely, L.; Li, F.; Veress, G. Effects of human papillomavirus type 16 oncoproteins on survivin gene expression. J. Gen. Virol. 2006, 87, 287-294.
-
(2006)
J. Gen. Virol.
, vol.87
, pp. 287-294
-
-
Borbely, A.A.1
Murvai, M.2
Konya, J.3
Beck, Z.4
Gergely, L.5
Li, F.6
Veress, G.7
-
82
-
-
84865130959
-
Cervical cancers require the continuous expression of the human papillomavirus type 16 E7 oncoprotein even in the presence of the viral E6 oncoprotein
-
Jabbar, S.F.; Park, S.; Schweizer, J.; Berard-Bergery, M.; Pitot, H.C.; Lee, D.; Lambert, P.F. Cervical cancers require the continuous expression of the human papillomavirus type 16 E7 oncoprotein even in the presence of the viral E6 oncoprotein. Cancer Res. 2012, 72, 4008-4016.
-
(2012)
Cancer Res.
, vol.72
, pp. 4008-4016
-
-
Jabbar, S.F.1
Park, S.2
Schweizer, J.3
Berard-Bergery, M.4
Pitot, H.C.5
Lee, D.6
Lambert, P.F.7
-
83
-
-
0024573764
-
Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms
-
Smotkin, D.; Prokoph, H.; Wettstein, F.O. Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms. J. Virol 1989, 63, 1441-1447.
-
(1989)
J. Virol
, vol.63
, pp. 1441-1447
-
-
Smotkin, D.1
Prokoph, H.2
Wettstein, F.O.3
-
84
-
-
0028824861
-
Translation of the human papillomavirus type 16 E7 oncoprotein from bicistronic mRNA is independent of splicing events within the E6 open reading frame
-
Stacey, S.N.; Jordan, D.; Snijders, P.J.; Mackett, M.; Walboomers, J.M.; Arrand, J.R. Translation of the human papillomavirus type 16 E7 oncoprotein from bicistronic mRNA is independent of splicing events within the E6 open reading frame. J. Virol. 1995, 69, 7023-7031.
-
(1995)
J. Virol.
, vol.69
, pp. 7023-7031
-
-
Stacey, S.N.1
Jordan, D.2
Snijders, P.J.3
Mackett, M.4
Walboomers, J.M.5
Arrand, J.R.6
-
85
-
-
70349269128
-
The human papillomavirus (HPV) E6* proteins from high-risk, mucosal HPVs can direct degradation of cellular proteins in the absence of full-length E6 protein
-
Pim, D.; Tomaic, V.; Banks, L. The human papillomavirus (HPV) E6* proteins from high-risk, mucosal HPVs can direct degradation of cellular proteins in the absence of full-length E6 protein. J. Virol. 2009, 83, 9863-9874.
-
(2009)
J. Virol.
, vol.83
, pp. 9863-9874
-
-
Pim, D.1
Tomaic, V.2
Banks, L.3
-
86
-
-
84855945551
-
p53 degradation activity, expression, and subcellular localization of E6 proteins from 29 human papillomavirus genotypes
-
Mesplede, T.; Gagnon, D.; Bergeron-Labrecque, F.; Azar, I.; Senechal, H.; Coutlee, F.; Archambault, J. p53 degradation activity, expression, and subcellular localization of E6 proteins from 29 human papillomavirus genotypes. J. Virol 2012, 86, 94-107.
-
(2012)
J. Virol
, vol.86
, pp. 94-107
-
-
Mesplede, T.1
Gagnon, D.2
Bergeron-Labrecque, F.3
Azar, I.4
Senechal, H.5
Coutlee, F.6
Archambault, J.7
-
87
-
-
34247165442
-
The large and small isoforms of human papillomavirus type 16 E6 bind to and differentially affect procaspase 8 stability and activity
-
Filippova, M.; Johnson, M.M.; Bautista, M.; Filippov, V.; Fodor, N.; Tungteakkhun, S.S.; Williams, K.; Duerksen-Hughes, P.J. The large and small isoforms of human papillomavirus type 16 E6 bind to and differentially affect procaspase 8 stability and activity. J. Virol 2007, 81, 4116-4129.
-
(2007)
J. Virol
, vol.81
, pp. 4116-4129
-
-
Filippova, M.1
Johnson, M.M.2
Bautista, M.3
Filippov, V.4
Fodor, N.5
Tungteakkhun, S.S.6
Williams, K.7
Duerksen-Hughes, P.J.8
-
88
-
-
0035956258
-
Biological activities and molecular targets of the human papillomavirus E7 oncoprotein
-
Munger, K.; Basile, J.; Duensing, S.; Eichten, A.; Gonzale, S.; Grace, M.; Zacny, L. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 2001, 20, 7888-7898.
-
(2001)
Oncogene
, vol.20
, pp. 7888-7898
-
-
Munger, K.1
Basile, J.2
Duensing, S.3
Eichten, A.4
Gonzale, S.5
Grace, M.6
Zacny, L.7
-
89
-
-
0031442175
-
Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein
-
Berezutskaya, E.; Yu, B.; Morozov, A.; Raychaudhuri, P.; Bagchi, S. Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein. Cell Growth Differ. 1997, 8, 1277-1286.
-
(1997)
Cell Growth Differ.
, vol.8
, pp. 1277-1286
-
-
Berezutskaya, E.1
Yu, B.2
Morozov, A.3
Raychaudhuri, P.4
Bagchi, S.5
-
90
-
-
0028227260
-
Apoptosis or retinoblastoma: Alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53
-
Howes, K.A.; Ransom, N.; Papermaster, D.S.; Lasudry, J.G.; Albert, D.M.; Windle, J.J. Apoptosis or retinoblastoma: Alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes Dev. 1994, 8, 1300-1310.
-
(1994)
Genes Dev.
, vol.8
, pp. 1300-1310
-
-
Howes, K.A.1
Ransom, N.2
Papermaster, D.S.3
Lasudry, J.G.4
Albert, D.M.5
Windle, J.J.6
-
91
-
-
0029093605
-
Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development
-
Pan, H.; Griep, A.E. Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development. Genes Dev. 1995, 9, 2157-2169.
-
(1995)
Genes Dev.
, vol.9
, pp. 2157-2169
-
-
Pan, H.1
Griep, A.E.2
-
92
-
-
0028334011
-
Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: Implications for tumor suppressor gene function in development
-
Pan, H.; Griep, A.E. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes Dev. 1994, 8, 1285-1299.
-
(1994)
Genes Dev.
, vol.8
, pp. 1285-1299
-
-
Pan, H.1
Griep, A.E.2
-
93
-
-
0034604086
-
Induction of S phase and apoptosis by the human papillomavirus type 16 E7 protein are separable events in immortalized rodent fibroblasts
-
Alunni-Fabbroni, M.; Littlewood, T.; Deleu, L.; Caldeira, S.; Giarre, M.; Dell' Orco, M.; Tommasino, M. Induction of S phase and apoptosis by the human papillomavirus type 16 E7 protein are separable events in immortalized rodent fibroblasts. Oncogene 2000, 19, 2277-2285.
-
(2000)
Oncogene
, vol.19
, pp. 2277-2285
-
-
Alunni-Fabbroni, M.1
Littlewood, T.2
Deleu, L.3
Caldeira, S.4
Giarre, M.5
Dell' Orco, M.6
Tommasino, M.7
-
94
-
-
1542285418
-
Simultaneous human papilloma virus type 16 E7 and cdk inhibitor p21 expression induces apoptosis and cathepsin B activation
-
Kaznelson, D.W.; Bruun, S.; Monrad, A.; Gjerlov, S.; Birk, J.; Ropke, C.; Norrild, B. Simultaneous human papilloma virus type 16 E7 and cdk inhibitor p21 expression induces apoptosis and cathepsin B activation. Virology 2004, 320, 301-312.
-
(2004)
Virology
, vol.320
, pp. 301-312
-
-
Kaznelson, D.W.1
Bruun, S.2
Monrad, A.3
Gjerlov, S.4
Birk, J.5
Ropke, C.6
Norrild, B.7
-
95
-
-
0032505107
-
The E7 protein of human papillomavirus type 16 sensitizes primary human keratinocytes to apoptosis
-
Stoppler, H.; Stoppler, M.C.; Johnson, E.; Simbulan-Rosenthal, C.M.; Smulson, M.E.; Iyer, S.; Rosenthal, D.S.; Schlegel, R. The E7 protein of human papillomavirus type 16 sensitizes primary human keratinocytes to apoptosis. Oncogene 1998, 17, 1207-1214.
-
(1998)
Oncogene
, vol.17
, pp. 1207-1214
-
-
Stoppler, H.1
Stoppler, M.C.2
Johnson, E.3
Simbulan-Rosenthal, C.M.4
Smulson, M.E.5
Iyer, S.6
Rosenthal, D.S.7
Schlegel, R.8
-
96
-
-
0035817789
-
HPV E6 and MAGUK protein interactions: Determination of the molecular basis for specific protein recognition and degradation
-
Thomas, M.; Glaunsinger, B.; Pim, D.; Javier, R.; Banks, L. HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation. Oncogene 2001, 20, 5431-5439.
-
(2001)
Oncogene
, vol.20
, pp. 5431-5439
-
-
Thomas, M.1
Glaunsinger, B.2
Pim, D.3
Javier, R.4
Banks, L.5
-
97
-
-
0032484553
-
Induction of apoptosis in human keratinocytes containing mutated p53 alleles and its inhibition by both the E6 and E7 oncoproteins
-
Magal, S.S.; Jackman, A.; Pei, X.F.; Schlegel, R.; Sherman, L. Induction of apoptosis in human keratinocytes containing mutated p53 alleles and its inhibition by both the E6 and E7 oncoproteins. Int. J. Cancer 1998, 75, 96-104.
-
(1998)
Int. J. Cancer
, vol.75
, pp. 96-104
-
-
Magal, S.S.1
Jackman, A.2
Pei, X.F.3
Schlegel, R.4
Sherman, L.5
-
98
-
-
34249876377
-
Human papillomavirus-16 E7 interacts with Siva-1 and modulates apoptosis in HaCaT human immortalized keratinocytes
-
Severino, A.; Abbruzzese, C.; Manente, L.; Valderas, A.A.; Mattarocci, S.; Federico, A.; Starace, G.; Chersi, A.; Mileo, A.M.; Paggi, M.G. Human papillomavirus-16 E7 interacts with Siva-1 and modulates apoptosis in HaCaT human immortalized keratinocytes. J. Cell. Physiol. 2007, 212, 118-125.
-
(2007)
J. Cell. Physiol.
, vol.212
, pp. 118-125
-
-
Severino, A.1
Abbruzzese, C.2
Manente, L.3
Valderas, A.A.4
Mattarocci, S.5
Federico, A.6
Starace, G.7
Chersi, A.8
Mileo, A.M.9
Paggi, M.G.10
-
99
-
-
0037050257
-
Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis
-
Aguilar-Lemarroy, A.; Gariglio, P.; Whitaker, N.J.; Eichhorst, S.T.; zur Hausen, H.; Krammer, P.H.; Rosl, F. Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis. Oncogene 2002, 21, 165-175.
-
(2002)
Oncogene
, vol.21
, pp. 165-175
-
-
Aguilar-Lemarroy, A.1
Gariglio, P.2
Whitaker, N.J.3
Eichhorst, S.T.4
Zur Hausen, H.5
Krammer, P.H.6
Rosl, F.7
-
100
-
-
0030864485
-
Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen conditions
-
Kim, C.Y.; Tsai, M.H.; Osmanian, C.; Graeber, T.G.; Lee, J.E.; Giffard, R.G.; DiPaolo, J.A.; Peehl, D.M.; Giaccia, A.J. Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen conditions. Cancer Res. 1997, 57, 4200-4204.
-
(1997)
Cancer Res.
, vol.57
, pp. 4200-4204
-
-
Kim, C.Y.1
Tsai, M.H.2
Osmanian, C.3
Graeber, T.G.4
Lee, J.E.5
Giffard, R.G.6
DiPaolo, J.A.7
Peehl, D.M.8
Giaccia, A.J.9
-
101
-
-
14344263000
-
Clinical relevance of human papillomavirus testing in cytopathology
-
Brink, A.A.; Zielinski, G.D.; Steenbergen, R.D.; Snijders, P.J.; Meijer, C.J. Clinical relevance of human papillomavirus testing in cytopathology. Cytopathology 2005, 16, 7-12.
-
(2005)
Cytopathology
, vol.16
, pp. 7-12
-
-
Brink, A.A.1
Zielinski, G.D.2
Steenbergen, R.D.3
Snijders, P.J.4
Meijer, C.J.5
-
102
-
-
2942618208
-
Pathogenesis of human papillomaviruses in differentiating epithelia
-
Longworth, M.S.; Laimins, L.A. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol. Mol. Biol. Rev. 2004, 68, 362-372.
-
(2004)
Microbiol. Mol. Biol. Rev.
, vol.68
, pp. 362-372
-
-
Longworth, M.S.1
Laimins, L.A.2
-
103
-
-
33646413672
-
The global health burden of infection-associated cancers in the year 2002
-
Parkin, D.M. The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer 2006, 118, 3030-3044.
-
(2006)
Int. J. Cancer
, vol.118
, pp. 3030-3044
-
-
Parkin, D.M.1
-
104
-
-
84871875432
-
Human papillomavirus disease in adolescents: Management and prevention
-
Widdice, L.E. Human papillomavirus disease in adolescents: Management and prevention. Adolesc Med. State Art Rev. 2012, 23, 192-206, xii-xiii.
-
(2012)
Adolesc Med. State Art Rev.
, vol.23
-
-
Widdice, L.E.1
-
105
-
-
34250850161
-
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: An interim analysis of a phase III double-blind, randomised controlled trial
-
Paavonen, J.; Jenkins, D.; Bosch, F.X.; Naud, P.; Salmeron, J.; Wheeler, C.M.; Chow, S.N.; Apter, D.L.; Kitchener, H.C.; Castellsague, X.; et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: An interim analysis of a phase III double-blind, randomised controlled trial. Lancet 2007, 369, 2161-2170.
-
(2007)
Lancet
, vol.369
, pp. 2161-2170
-
-
Paavonen, J.1
Jenkins, D.2
Bosch, F.X.3
Naud, P.4
Salmeron, J.5
Wheeler, C.M.6
Chow, S.N.7
Apter, D.L.8
Kitchener, H.C.9
Castellsague, X.10
-
106
-
-
45149113332
-
HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: A multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy
-
Oehler-Janne, C.; Huguet, F.; Provencher, S.; Seifert, B.; Negretti, L.; Riener, M.O.; Bonet, M.; Allal, A.S.; Ciernik, I.F. HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy. J. Clin. Oncol. 2008, 26, 2550-2557.
-
(2008)
J. Oncol.
, vol.26
, pp. 2550-2557
-
-
Oehler-Janne, C.1
Huguet, F.2
Provencher, S.3
Seifert, B.4
Negretti, L.5
Riener, M.O.6
Bonet, M.7
Allal, A.S.8
Ciernik, I.F.9
-
107
-
-
3242705962
-
Human papillomavirus infection and disease in HIV-infected individuals
-
Hagensee, M.E.; Cameron, J.E.; Leigh, J.E.; Clark, R.A. Human papillomavirus infection and disease in HIV-infected individuals. Am. J. Med. Sci 2004, 328, 57-63.
-
(2004)
Am. J. Med. Sci
, vol.328
, pp. 57-63
-
-
Hagensee, M.E.1
Cameron, J.E.2
Leigh, J.E.3
Clark, R.A.4
-
108
-
-
0031554081
-
Therapeutic approaches to genital warts
-
Beutner, K.R.; Ferenczy, A. Therapeutic approaches to genital warts. Am. J. Med. 1997, 102, 28-37.
-
(1997)
Am. J. Med.
, vol.102
, pp. 28-37
-
-
Beutner, K.R.1
Ferenczy, A.2
-
109
-
-
0031976655
-
Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts
-
Beutner, K.R.; Tyring, S.K.; Trofatter, K.F., Jr.; Douglas, J.M., Jr.; Spruance, S.; Owens, M.L.; Fox, T.L.; Hougham, A.J.; Schmitt, K.A. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts. Antimicrob Agents Chemother 1998, 42, 789-794.
-
(1998)
Antimicrob Agents Chemother
, vol.42
, pp. 789-794
-
-
Beutner, K.R.1
Tyring, S.K.2
Trofatter Jr., K.F.3
Douglas Jr., J.M.4
Spruance, S.5
Owens, M.L.6
Fox, T.L.7
Hougham, A.J.8
Schmitt, K.A.9
-
110
-
-
33646465686
-
An evidence-based review of medical and surgical treatments of genital warts
-
Scheinfeld, N.; Lehman, D.S. An evidence-based review of medical and surgical treatments of genital warts. Dermatol. Online J. 2006, 12, 5.
-
(2006)
Dermatol. Online J.
, vol.12
, pp. 5
-
-
Scheinfeld, N.1
Lehman, D.S.2
-
111
-
-
85056055141
-
Small molecule inhibitors of human papillomavirus protein-protein interactions
-
D'Abramo, C.M.; Archambault, J. Small molecule inhibitors of human papillomavirus protein-protein interactions. Open Virol. J. 2011, 5, 80-95.
-
(2011)
Open Virol. J.
, vol.5
, pp. 80-95
-
-
D'Abramo, C.M.1
Archambault, J.2
-
112
-
-
0031716454
-
Molecular targets for human papillomaviruses: Prospects for antiviral therapy
-
Phelps, W.C.; Barnes, J.A.; Lobe, D.C. Molecular targets for human papillomaviruses: Prospects for antiviral therapy. Antivir. Chem. Chemother. 1998, 9, 359-377.
-
(1998)
Antivir. Chem. Chemother.
, vol.9
, pp. 359-377
-
-
Phelps, W.C.1
Barnes, J.A.2
Lobe, D.C.3
-
113
-
-
0346731236
-
Discovery of small-molecule inhibitors of the ATPase activity of human papillomavirus E1 helicase
-
Faucher, A.M.; White, P.W.; Brochu, C.; Grand-Maitre, C.; Rancourt, J.; Fazal, G. Discovery of small-molecule inhibitors of the ATPase activity of human papillomavirus E1 helicase. J. Med. Chem. 2004, 47, 18-21.
-
(2004)
J. Med. Chem.
, vol.47
, pp. 18-21
-
-
Faucher, A.M.1
White, P.W.2
Brochu, C.3
Grand-Maitre, C.4
Rancourt, J.5
Fazal, G.6
-
114
-
-
36348949210
-
Human papillomavirus E6 proteins mediate resistance to interferon-induced growth arrest through inhibition of p53 acetylation
-
Hebner, C.; Beglin, M.; Laimins, L.A. Human papillomavirus E6 proteins mediate resistance to interferon-induced growth arrest through inhibition of p53 acetylation. J. Virol. 2007, 81, 12740-12747.
-
(2007)
J. Virol.
, vol.81
, pp. 12740-12747
-
-
Hebner, C.1
Beglin, M.2
Laimins, L.A.3
-
115
-
-
0037325976
-
Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system
-
Scheffner, M.; Whitaker, N.J. Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system. Semin Cancer Biol. 2003, 13, 59-67.
-
(2003)
Semin Cancer Biol.
, vol.13
, pp. 59-67
-
-
Scheffner, M.1
Whitaker, N.J.2
-
116
-
-
12344295621
-
E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation
-
Thomas, M.C.; Chiang, C.M. E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation. Mol. Cell. 2005, 17, 251-264.
-
(2005)
Mol. Cell.
, vol.17
, pp. 251-264
-
-
Thomas, M.C.1
Chiang, C.M.2
-
117
-
-
33747881135
-
Identification of inhibitors to papillomavirus type 16 E6 protein based on three-dimensional structures of interacting proteins
-
Baleja, J.D.; Cherry, J.J.; Liu, Z.; Gao, H.; Nicklaus, M.C.; Voigt, J.H.; Chen, J.J.; Androphy, E.J. Identification of inhibitors to papillomavirus type 16 E6 protein based on three-dimensional structures of interacting proteins. Antiviral Res. 2006, 72, 49-59.
-
(2006)
Antiviral Res.
, vol.72
, pp. 49-59
-
-
Baleja, J.D.1
Cherry, J.J.2
Liu, Z.3
Gao, H.4
Nicklaus, M.C.5
Voigt, J.H.6
Chen, J.J.7
Androphy, E.J.8
-
118
-
-
62449168519
-
TRAIL agonists on clinical trials for cancer therapy: The promises and the challenges
-
Bellail, A.C.; Qi, L.; Mulligan, P.; Chhabra, V.; Hao, C. TRAIL agonists on clinical trials for cancer therapy: the promises and the challenges. Rev. Recent Clin. Trials 2009, 4, 34-41.
-
(2009)
Rev. Recent Clin. Trials
, vol.4
, pp. 34-41
-
-
Bellail, A.C.1
Qi, L.2
Mulligan, P.3
Chhabra, V.4
Hao, C.5
-
119
-
-
13144297792
-
Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts
-
El-Zawahry, A.; McKillop, J.; Voelkel-Johnson, C. Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts. BMC Cancer 2005, 5, 2.
-
(2005)
BMC Cancer
, vol.5
, pp. 2
-
-
El-Zawahry, A.1
McKillop, J.2
Voelkel-Johnson, C.3
-
120
-
-
69949110775
-
Mapatumumab, a fully human agonistic monoclonal antibody that targets TRAIL-R1, in combination with gemcitabine and cisplatin: A phase I study
-
Mom, C.H.; Verweij, J.; Oldenhuis, C.N.; Gietema, J.A.; Fox, N.L.; Miceli, R.; Eskens, F.A.; Loos, W.J.; de Vries, E.G.; Sleijfer, S. Mapatumumab, a fully human agonistic monoclonal antibody that targets TRAIL-R1, in combination with gemcitabine and cisplatin: a phase I study. Clin. Cancer Res. 2009, 15, 5584-5590.
-
(2009)
Clin. Cancer Res.
, vol.15
, pp. 5584-5590
-
-
Mom, C.H.1
Verweij, J.2
Oldenhuis, C.N.3
Gietema, J.A.4
Fox, N.L.5
Miceli, R.6
Eskens, F.A.7
Loos, W.J.8
de Vries, E.G.9
Sleijfer, S.10
-
121
-
-
0037108712
-
Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with chemotherapeutic agents on patients' colon tumors grown in SCID mice
-
Naka, T.; Sugamura, K.; Hylander, B.L.; Widmer, M.B.; Rustum, Y.M.; Repasky, E.A. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with chemotherapeutic agents on patients' colon tumors grown in SCID mice. Cancer Res. 2002, 62, 5800-5806.
-
(2002)
Cancer Res.
, vol.62
, pp. 5800-5806
-
-
Naka, T.1
Sugamura, K.2
Hylander, B.L.3
Widmer, M.B.4
Rustum, Y.M.5
Repasky, E.A.6
-
122
-
-
77954216859
-
Development of small-molecule inhibitors of the group I p21-activated kinases, emerging therapeutic targets in cancer
-
Yi, C.; Maksimoska, J.; Marmorstein, R.; Kissil, J.L. Development of small-molecule inhibitors of the group I p21-activated kinases, emerging therapeutic targets in cancer. Biochem. Pharmacol. 2010, 80, 683-689.
-
(2010)
Biochem. Pharmacol.
, vol.80
, pp. 683-689
-
-
Yi, C.1
Maksimoska, J.2
Marmorstein, R.3
Kissil, J.L.4
-
123
-
-
84857360036
-
Small molecule inhibitors of the HPV16-E6 interaction with caspase 8
-
Yuan, C.H.; Filippova, M.; Tungteakkhun, S.S.; Duerksen-Hughes, P.J.; Krstenansky, J.L. Small molecule inhibitors of the HPV16-E6 interaction with caspase 8. Bioorg. Med. Chem. Lett. 2012, 22, 2125-2129.
-
(2012)
Bioorg. Med. Chem. Lett.
, vol.22
, pp. 2125-2129
-
-
Yuan, C.H.1
Filippova, M.2
Tungteakkhun, S.S.3
Duerksen-Hughes, P.J.4
Krstenansky, J.L.5
|